These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18451134)

  • 1. Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions.
    Guillaud M; Zhang L; Poh C; Rosin MP; MacAulay C
    Cancer Res; 2008 May; 68(9):3099-107. PubMed ID: 18451134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated classification of oral premalignant lesions using image cytometry and Random Forests-based algorithms.
    Baik J; Ye Q; Zhang L; Poh C; Rosin M; MacAulay C; Guillaud M
    Cell Oncol (Dordr); 2014 Jun; 37(3):193-202. PubMed ID: 24817187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer.
    Zhang L; Poh CF; Williams M; Laronde DM; Berean K; Gardner PJ; Jiang H; Wu L; Lee JJ; Rosin MP
    Cancer Prev Res (Phila); 2012 Sep; 5(9):1081-9. PubMed ID: 22911111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
    Epstein JB; Sciubba J; Silverman S; Sroussi HY
    Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
    Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
    Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity: a potential tool in management of oral premalignant lesions?
    Zhang L; Rosin MP
    J Oral Pathol Med; 2001 Oct; 30(9):513-20. PubMed ID: 11555152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx.
    Tabor MP; Braakhuis BJ; van der Wal JE; van Diest PJ; Leemans CR; Brakenhoff RH; Kummer JA
    J Pathol; 2003 Mar; 199(3):354-60. PubMed ID: 12579537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
    Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
    Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis.
    Yang Y; Li YX; Yang X; Jiang L; Zhou ZJ; Zhu YQ
    BMC Cancer; 2013 Mar; 13():129. PubMed ID: 23510112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.
    Ho MW; Field EA; Field JK; Risk JM; Rajlawat BP; Rogers SN; Steele JC; Triantafyllou A; Woolgar JA; Lowe D; Shaw RJ
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):594-9. PubMed ID: 23601832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the diagnosis of oral premalignant and malignant lesions.
    Epstein JB; Zhang L; Rosin M
    J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia.
    Scott IS; Odell E; Chatrath P; Morris LS; Davies RJ; Vowler SL; Laskey RA; Coleman N
    Br J Cancer; 2006 Apr; 94(8):1170-5. PubMed ID: 16622441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma.
    Chaves FN; Bezerra TMM; Moraes DC; Costa SFDS; Silva PGB; Alves APNN; Costa FWG; Bernardes VF; Pereira KMA
    Exp Mol Pathol; 2020 Feb; 112():104341. PubMed ID: 31730755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic imbalances in precancerous tissues signal oral cancer risk.
    Garnis C; Chari R; Buys TP; Zhang L; Ng RT; Rosin MP; Lam WL
    Mol Cancer; 2009 Jul; 8():50. PubMed ID: 19627613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
    Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
    Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
    Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of oral lichen planus. A premalignant lesion?
    Zhang L; Michelsen C; Cheng X; Zeng T; Priddy R; Rosin MP
    Am J Pathol; 1997 Aug; 151(2):323-7. PubMed ID: 9250145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
    Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
    Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of a fluorescence visualization system for the detection of oral precancerous and early cancerous lesions.
    Ohnishi Y; Fujii T; Ugaki Y; Yasui H; Watanabe M; Dateoka S; Kakudo K
    Oncol Rep; 2016 Jul; 36(1):514-20. PubMed ID: 27121913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Progression of Low-Grade Oral Dysplasia Using Brushing-Based DNA Ploidy and Chromatin Organization Analysis.
    Datta M; Laronde DM; Rosin MP; Zhang L; Chan B; Guillaud M
    Cancer Prev Res (Phila); 2021 Dec; 14(12):1111-1118. PubMed ID: 34376461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.